Biblio

Author Title Type [ Year

]

Filters: Author is Hamerschlak, Nelson [Clear All Filters]

2024

Gagelmann N, Hobbs GS, Campodonico E, Helbig G, Novak P, Schroeder T, Schneider A, Rautenberg C, Reinhardt HChristian, Bosques L, et al. Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis. Am J Hematol. 2024.

2023

Mariano B, Hamerschlak N, Vera M, Belén C, Andrés GP, Gonzalo F, José RJ, Adriana V, Alberto GC, Georgina B, et al. Donor Age Influences Graft-Versus-Host Disease Relapse-Free Survival after Allogeneic Stem Cell Transplant in Elderly Patients in Two Countries from Latin America. Hematol Oncol Stem Cell Ther. 2023;16(4):330-336.

Szabolcs P, Mazor RD, Yackoubov D, Levy S, Stiff P, Rezvani A, Hanna R, Wagner J, Keating A, Lindemans CA, et al. Immune Reconstitution Profiling Suggests Antiviral Protection After Transplantation with Omidubicel: a Phase 3 Substudy. Transplant Cell Ther. 2023.

Lin C, Schwarzbach A, Sanz J, Montesinos P, Stiff P, Parikh S, Brunstein C, Cutler C, Lindemans CA, Hanna R, et al. Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials. Transplant Cell Ther. 2023.

Arcuri LJavier, Ribeiro AAlice Feit, Hamerschlak N, Kerbauy MNassif. Posttransplant cyclophosphamide beyond haploidentical transplantation. Ann Hematol. 2023.

2022

Tokaz MC, Baldomero H, Cowan AJ, Saber W, Greinix H, Koh MBc, Kröger N, Mohty M, Galeano S, Okamoto S, et al. An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Transplant Cell Ther. 2022.

Arcuri LJavier, Kerbauy MNassif, Kerbauy LNassif, Santos FPires de S, Ribeiro AAlice Feit, Hamerschlak N. ATG in HLA-matched, peripheral blood, hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome: a secondary analysis of a CIBMTR database. Transplant Cell Ther. 2022.

Koch Lde Oliveir, Pereira AZ, Hamerschlak N, Castro Ado Amaral, Tachibana A, Victor Eda Silva, Filho RJesus Garc. Influence of body composition assessed by computed tomography on mortality in older adults undergoing hematopoietic stem cell transplantation. Nutr Clin Pract. 2022.

Silva WF, Cysne DN, Kerbauy MN, Colturato I, Maia ACarolina A, Tucunduva L, Barros GMn, Colturato VAr, Hamerschlak N, Rocha V. Predictive Factors and Outcomes After Allogeneic Stem-Cell Transplantation for Adults with Acute Lymphoblastic Leukemia in Brazil. Transplant Cell Ther. 2022.

Ali N, Sharma AArunkumar, de Rezende ACarolina P, Otegbeye F, Latif BMuhammad, Kerbauy MNassif, Cooper BW, Sanchez G, Metheny L, Bal SK, et al. Targeted Marrow Irradiation Intensification of Reduced Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2022.

2020

Barban JBernardo, Simões BPinto, Moraes BDel Guerra, da Anunciação CRehem, da Rocha CSantos, Pintor DCristina Q, Guerra DCristina, Silva DAndrade, Brandão Ede Castro, Kerbauy F, et al. Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Adults. Einstein (Sao Paulo). 2020;18:AE4530.

Tavares Rde Cássia, Bonfim CSales, Seber A, Lermontov SPereira, Coulturato V, Zecchin VGottardell, Ribeiro L, Fernandes JFolloni, Daudt LEsteves, Grecco CS, et al. Hematopoietic cell transplantation in pediatric patients with acute leukemias or myelodysplastic syndrome using unrelated adult or umbilical cord blood donors in Brazil. Pediatr Transplant. 2020:e13789.

Arcuri LJavier, Nabhan SKanaan, Cunha R, Nichele S, Ribeiro AAlice Feit, Fernandes JFolloni, Daudt LEsteves, Rodrigues ALuiza Melo, Arrais-Rodrigues C, Seber A, et al. Impact of CD34 cell dose and conditioning regimen on outcomes after Haploidentical donor hematopoietic stem cell transplantation with post-transplant cyclophosphamide for relapsed/refractory severe aplastic anemia: Haploidentical HCT with PTCy for SAA. Biol Blood Marrow Transplant. 2020.

Duarte FBarroso, Moura AThawanny G, Funke VAraújo Mo, Colturato VAntônio R, Hamerschlak N, Vilela NCosta, Lopes LFernando, Macedo MCristina M, Vigorito ACelso, Soares RDaniel de, et al. IMPACT OF TREATMENT PRIOR TO ALLOGENEIC TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME: RESULTS OF THE LATIN AMERICAN BONE MARROW TRANSPLANT REGISTRY. Biol Blood Marrow Transplant. 2020.

Fernandes JFolloni, Nichele S, Arcuri LJavier, Ribeiro L, Netto GZamperlini, Loth G, Rodrigues ALuiza Melo, Kuwahara C, Koliski A, Trennepohl J, et al. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases. Biol Blood Marrow Transplant. 2020.

L Dupuis L, Quinones CM, Ritchie J, Carpenter PA, Bauters T, Yeh RF, Anasetti C, Boelens JJ, Hamerschlak N, Hassan M, et al. Response to Kawedia et al Letter to Editor in Response to the Article by McCune Et Al "Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement". Biol Blood Marrow Transplant. 2020.

2016

Kerbauy LNassif, Parmar S, Kutner JMauro, de Gusmão BMoreno, Hamerschlak N. Hematological approaches to multiple myeloma: trends from a Brazilian subset of hematologists. A cross-sectional study. Sao Paulo Med J. 2016;134(4):335-341.

2014

Normanton M, Alvarenga H, Hamerschlak N, Ribeiro A, Kondo A, Rizzo LVicente, Marti LCavalheiro. Interleukin 7 Plays a Role in T Lymphocyte Apoptosis Inhibition Driven by Mesenchymal Stem Cell without Favoring Proliferation and Cytokines Secretion. PLoS One. 2014;9(9):e106673.